Results 31 to 40 of about 51,654 (292)

Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial [PDF]

, 2013
Background : The use of a drug-eluting balloon for the treatment of de novo coronary artery lesions remains to be evaluated. A previous trial in patients with stable and unstable angina comparing a bare metal stent mounted on a drug-eluting balloon with ...
Chae, In-Ho, Cho, Young-Suk, Choi, Dong-Ju, Oh, Il-Young, Park, Sang-Don, Suh, Jung-Won, Yoon, Chang-Hwan, Youn, Tae-Jin   +7 more
core   +1 more source

Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]

, 2012
Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A, Koppensteiner, Renate, Lammer, Johannes, Mellon, Rajeev M, Scheinert, Dierk, Schroë, Herman, Schwartz, Lewis B, Vermassen, Frank   +7 more
core   +2 more sources

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger, Boeckstegers, Peter, Heitzer, Thomas, Hoffmann, Rainer, Köster, Ralf, Pohl, Tilmann   +5 more
core   +2 more sources

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis

Coronary Artery Disease, 2019
Approximately, 10-20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated implantation of new-generation DES.A total of 172 ...
Guozhong Wang, Chen Qing, Quanming Zhao, Zhang Xiaojiang, Lei Tian, Xiaoxia Zhang   +5 more
openaire   +3 more sources

Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model

Chinese Medical Journal, 2016
Background: Currently available silicone and metallic stents for tracheal stenosis are associated with many problems. Granulation proliferation is one of the main complications.
Ting Wang, Jie Zhang, Juan Wang, Ying-Hua Pei, Xiao-Jian Qiu, Yu-Ling Wang   +5 more
doaj   +1 more source

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, Rizkan Triatmaja   +3 more
doaj   +1 more source

Advances in Drug Delivery via Biodegradable Ureteral Stent for the Treatment of Upper Tract Urothelial Carcinoma

Frontiers in Pharmacology, 2020
Drug eluting ureteral stent is an effective means for local drug delivery to the urinary tract. It can potentially solve a variety of upper urinary tract problems, such as stent-related urinary tract infections and discomfort, ureteral stricture, and ...
Hongli Shan, Zhongshuai Cao, Changliang Chi, Jixue Wang, Xiaoqing Wang, Jingyan Tian, Bing Yu   +6 more
doaj   +1 more source

Real-time 3D Shape Instantiation from Single Fluoroscopy Projection for Fenestrated Stent Graft Deployment [PDF]

IEEE Robotics and Automation Letters 2018, 2017
Robot-assisted deployment of fenestrated stent grafts in Fenestrated Endovascular Aortic Repair (FEVAR) requires accurate geometrical alignment. Currently, this process is guided by 2D fluoroscopy, which is uninformative and error prone. In this paper, a real-time framework is proposed to instantiate the 3D shape of a fenestrated stent graft based on ...
arxiv   +1 more source

Safety of short-term dual antiplatelet therapy after drug-eluting stents:An updated meta-analysis with direct and adjusted indirect comparison of randomized control trials [PDF]

, 2014
Background: Duration of dual antiplatelet therapy (DAPT) following drug-eluting stents (DES) remains controversial and is a topic of ongoing research.
Bulluck, Heerajnarain, Kwok, Chun Shing, Loke, Yoon K., Ryding, Alisdair D.   +3 more
core   +1 more source

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial

Trials, 2012
Background Neointimal hyperplasia plays a pivotal role in the pathogenesis of in-stent restenosis in patients undergoing percutaneous coronary interventions.
Burzotta Francesco, Brancati Marta, Trani Carlo, Porto Italo, Tommasino Antonella, De Maria Gianluigi, Niccoli Giampaolo, Leone Antonio, Coluccia Valentina, Schiavoni Giovanni, Crea Filippo   +10 more
doaj   +1 more source